Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aims: To develop a pharmacokinetic–pharmacodynamic model describing the time‐course of QT interval prolongation after citalopram overdose and to evaluate the effect of charcoal on the relative risk of developing abnormal QT and heart‐rate combinations. Methods: Plasma concentrations and electrocardiograph (ECG) data from 52 patients after 62 citalopram overdose events were analysed in WinBUGS using a Bayesian approach. The reported doses ranged from 20 to 1700 mg and on 17 of the events a single dose of activated charcoal was administered. The developed pharmacokinetic–pharmacodynamic model was used for predicting the probability of having abnormal combinations of QT‐RR, which was assumed to be related to an increased risk for torsade de pointes (TdP). Results: The absolute QT interval was related to the observed heart rate with an estimated individual heart‐rate correction factor [α = 0.36, between‐subject coefficient of variation (CV) = 29%]. The heart‐rate corrected QT interval was linearly dependent on the predicted citalopram concentration (slope = 40 ms l mg−1, between‐subject CV = 70%) in a hypothetical effect‐compartment (half‐life of effect‐delay = 1.4 h). The heart‐rate corrected QT was predicted to be higher in women than in men and to increase with age. Administration of activated charcoal resulted in a pronounced reduction of the QT prolongation and was shown to reduce the risk of having abnormal combinations of QT‐RR by approximately 60% for citalopram doses above 600 mg. Conclusion: Citalopram caused a delayed lengthening of the QT interval. Administration of activated charcoal was shown to reduce the risk that the QT interval exceeds a previously defined threshold and therefore is expected to reduce the risk of TdP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The QT Interval and Torsade de Pointes
Moss, A. J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00002 · Cited by 154
Buckley, N. A., Buckley, N., Whyte, I. M., O'Connell, D. L., & Dawson, A. H. (1999) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100102452 · Cited by 112
Cited by
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
Activated charcoal for acute overdose: a reappraisal
Juurlink, D. N. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12793 · Cited by 128
Spindelegger, C. J., Papageorgiou, K., Grohmann, R., Engel, R., Greil, W., Konstantinidis, A., Agelink, M. W., Bleich, S., Ruether, E., Toto, S., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu080 · Cited by 82
Cardiovascular adverse effects of newer antidepressants
Mago, R., Tripathi, N., & Andrade, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908709 · Cited by 54
“Adding support to the relationship between citalopram overdose and QTc prolongation is the finding that in the 52 patients who had overdosed on citalopram, QTc was linearly related to the predicted plasma citalopram concentration [58].”
BackgroundHoegberg, L. C. G., Gosselin, S., Buckley, N. A., Wood, D. M., Shepherd, G., Hanley, J., Bates, N., St-Onge, M., Caravati, E. M., Smith, S. W., et al. (2026) · Clinical Toxicology · doi:10.1080/15563650.2025.2609807 · Cited by 7
Metadata
- Authors
- Friberg, L. E., Isbister, G. K., & Duffull, S. B.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2005-12
- Volume
- 61
- Issue
- 2
- Pages
- 177-190
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2036823079
- Cited by
- 92
- References
- 2
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.